US Broker Ratings

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Navigating a Challenging Market with Innovative Diagnostics

Bio-Rad Laboratories, Inc. (NYSE: BIO), a key player in the medical devices industry, stands at the forefront of healthcare innovation, offering a wide array of life..

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: A Biotech Powerhouse with 33.59% Upside Potential

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) is gaining attention in the biotech sector, primarily due to its innovative approach to treating metabolic dysfunction-associated steatohepatitis (MASH). With a..

Centene Corporation (CNC) Stock Analysis: Evaluating the 6.22% Potential Upside Amidst Healthcare Industry Dynamics

Centene Corporation (NYSE: CNC), a major player in the healthcare plans industry, is making waves in the investment community with a potential upside of 6.22% according..

Teleflex Incorporated (TFX) Stock Report: Analyzing a 11.21% Potential Upside in the Healthcare Sector

Teleflex Incorporated (NYSE: TFX), a key player in the healthcare sector specializing in medical instruments and supplies, presents a compelling opportunity for investors. With a market..

Ascendis Pharma A/S (ASND) Stock Analysis: Healthcare Innovator with a 25% Upside Potential

Ascendis Pharma A/S (NASDAQ: ASND), a Denmark-based biopharmaceutical company, is making significant waves in the biotechnology sector with its innovative TransCon-based therapies. With a robust market..

Option Care Health, Inc. (OPCH) Stock Analysis: Navigating Growth with a 19% Upside Potential

Option Care Health, Inc. (NASDAQ: OPCH) stands out in the healthcare sector as a prominent provider of home and alternate site infusion services across the United..

Charles River Laboratories (CRL) Stock Analysis: Navigating an Evolving Landscape with a $13.49 Billion Market Cap

Charles River Laboratories International, Inc. (NYSE: CRL) stands as a pivotal player in the healthcare sector, operating within the diagnostics and research industry. With a robust..

Qiagen N.V. (QGEN) Stock Analysis: Exploring Its Growth Potential and Strategic Position in Diagnostics

Qiagen N.V. (QGEN), a prominent player in the healthcare sector, is carving out a significant niche in the diagnostics and research industry. Based in Venlo, Netherlands,..

IDEXX Laboratories, Inc. (IDXX) Stock Analysis: Unpacking a 26.86% Potential Upside in the Diagnostics & Research Sector

Investors with an eye on the healthcare sector may find IDEXX Laboratories, Inc. (NASDAQ: IDXX) a compelling opportunity, especially given its significant potential upside of 26.86%...

Henry Schein, Inc. (HSIC) Stock Analysis: Exploring Growth Potential Amidst a 8.68% Upside

Henry Schein, Inc. (NASDAQ: HSIC), a stalwart in the healthcare sector, stands as a leading player in the medical distribution industry. With a market capitalization of..

HCA Healthcare, Inc. (HCA) Stock Analysis: Exploring Growth Potential with a 12.33% Upside

In the dynamic landscape of the healthcare sector, HCA Healthcare, Inc. (NYSE: HCA) stands out as a formidable player. With a market capitalization of $87.61 billion,..

Bausch + Lomb Corporation (BLCO) Stock Analysis: Eyeing a 9.24% Potential Upside in the Healthcare Sector

Bausch + Lomb Corporation (NYSE: BLCO), a prominent player in the healthcare sector with a focus on medical instruments and supplies, is capturing investor attention with..

Exelixis, Inc. (EXEL) Stock Analysis: Evaluating the 3.31% Upside with Strong Revenue Growth

Exelixis, Inc. (NASDAQ: EXEL), a prominent player in the biotechnology industry, continues to make strides in the healthcare sector with its innovative oncology treatments. With a..

Zoetis Inc. (ZTS) Stock Analysis: Potential 36.79% Upside Amid Healthcare Sector Dynamics

Zoetis Inc. (NYSE: ZTS), a leading player in the healthcare sector specializing in animal health solutions, presents a unique investment opportunity. With a market capitalization of..

Baxter International Inc. (BAX) Stock Analysis: Evaluating Growth Potential with Insightful Valuation Metrics

Baxter International Inc. (NYSE: BAX), a stalwart in the healthcare sector, is a company with a rich history dating back to its incorporation in 1931. Headquartered..

Telix Pharmaceuticals Limited (TLX): Analyst Ratings Signal an 80% Upside Potential for this Biotech Stock

Telix Pharmaceuticals Limited (ASX: TLX), an Australian-based biopharmaceutical company, is making waves in the healthcare sector with its promising pipeline of radiopharmaceuticals. As a commercial-stage company,..

Regeneron Pharmaceuticals (REGN): Investor Outlook with Strong Buy Consensus and Notable Growth Potential

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) stands as a formidable player in the biotechnology sector with a market capitalization of $82.72 billion. The company has consistently demonstrated..

Johnson & Johnson (JNJ)

⚠️ No article content returned.

..

West Pharmaceutical Services (WST): Analyst Consensus and 15.83% Potential Upside

West Pharmaceutical Services, Inc. (WST), a key player in the healthcare sector with a focus on medical instruments and supplies, has been capturing investor attention with..

Merck & Company, Inc. (MRK) Investor Outlook: Exploring Growth with a Robust Pipeline and Strategic Collaborations

Merck & Company, Inc. (NYSE: MRK), a titan in the healthcare sector, continues to intrigue investors with its strategic collaborations and a broad portfolio of pharmaceutical..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds